Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous β2-adrenoceptor haplotypes at positions 16 and 27

British Journal of Clinical Pharmacology

Volumn 57, Issue 1, 2004, Pages 100-104

  Lee, Daniel K C ^a   Bates, Caroline E ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

2 adrenoceptor polymorphism; 2 adrenoceptor haplotype; Asthma; Diastolic blood pressure; Heart rate; Salbutamol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; POTASSIUM; SALBUTAMOL; SALMETEROL;

ADULT; ARTICLE; ASTHMA; BLOOD SAMPLING; CAUCASIAN; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HAPLOTYPE; HEART RATE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SIDE EFFECT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HAPLOTYPES; HOMOZYGOTE; HUMANS; MALE; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0346688577     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2003.01978.x     Document Type: Article

References (22)

1. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 1993; 268: 23116-21.
2. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995; 13: 25-33.
3. 2-adrenergic receptors: relevance to asthma. J Allergy Clin Immunol 2000; 105: 5487-5492.
4. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000; 97: 10483-8.
5. 2-adrenoceptors in asthmatic patients. Chest 1999; 115: 324-8.
6. Lipworth BJ, McDevitt DG. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol 1989; 36: 239-45.
7. Lipworth BJ, Clark RA, Dhillon DP, Brown RA, McDevitt DG. β-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma. Br J Clin Pharmacol 1988; 26: 527-33.
8. 2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population. Clin Exp Allergy 1998; 28: 442-8.
9. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics - 2002. J Allergy Clin Immunol 2002; 110: S141-S219.
10. 2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 1999; 33: 1425-30.
11. 2-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 2000; 36: 371-5.
12. 2- adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. J Allergy Clin Ilmmunol 1998; 101: 337-41.
13. 2-adrenoceptor - regulation and bronchodilatation. Eur J Clin Pharmacol 1999; 55: 431-6.
14. 2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001; 345: 1030-5.
15. 1-adrenoceptor selectivity of bisoprolol. Eur J Clin Pharmacol 1991; 40: 135-9.
16. Lipworth BJ, Tregaskis BF, McDevitt DG. Comparison of hypokalaemic, electrocardiographs and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects. Eur J Clin Pharmacol 1991; 40: 255-60.
17. 2-adrenoceptor blockade. Br J Clin Pharmacol 1989; 28: 95-102.
18. 2 activity of inhaled fenoterol and salbutamol in normal subjects. Thorax 1993; 48: 656-8.
19. 2-agonist therapy. Eur J Clin Pharmacol 1998; 54: 377-81.
20. 2-adrenoceptor down-regulation after regular inhaled formoterol. Chest 1999; 115: 623-8.
21. Chowienczyk PJ, Kelly RP, MacCallum H, Millasseau SC, Andersson TL, Gosling RG, et al. Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol 1999; 34: 2007-14.
22. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, et al. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002; 22: 147-52.